Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.165 USD | +0.36% | +7.07% | -2.91% |
05-08 | BofA Securities Starts Sutro Biopharma With Buy Rating | MT |
04-30 | Sutro Biopharma, Inc. Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.91% | 339M | |
+5.72% | 109B | |
+11.11% | 105B | |
-0.38% | 22.25B | |
-12.08% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.31% | 16.85B | |
+3.07% | 13.76B | |
+36.07% | 12.46B |
- Stock Market
- Equities
- STRO Stock
- News Sutro Biopharma, Inc.
- Wedbush Cuts Sutro Biopharma's Price Target to $30 From $37, Citing Adjusted Timelines for STRO-001, -002; Outperform Rating Kept